• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The frequency of major genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups.亚洲、夏威夷原住民和太平洋岛民亚组女性主要遗传多态性的频率。
Per Med. 2022 Jul;19(4):327-339. doi: 10.2217/pme-2021-0175. Epub 2022 Jun 24.
2
The frequency of major , and variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.亚洲、夏威夷原住民和太平洋岛民女性亚组中主要和变体的频率:对个体化他汀类药物剂量的影响。
Pharmacogenomics. 2023 May;24(7):381-398. doi: 10.2217/pgs-2023-0043. Epub 2023 May 24.
3
Genetic assessment of hyperuricemia and gout in Asian, Native Hawaiian, and Pacific Islander subgroups of pregnant women: biospecimens repository cross-sectional study.亚洲、夏威夷原住民和太平洋岛民孕妇亚组高尿酸血症和痛风的基因评估:生物样本库横断面研究
BMC Rheumatol. 2022 Jan 6;6(1):1. doi: 10.1186/s41927-021-00239-7.
4
Racial Bias Beliefs Related to COVID-19 Among Asian Americans, Native Hawaiians, and Pacific Islanders: Findings From the COVID-19 Effects on the Mental and Physical Health of Asian Americans and Pacific Islanders Survey Study (COMPASS).亚裔美国人、夏威夷原住民和太平洋岛民中与 COVID-19 相关的种族偏见信念:来自 COVID-19 对亚裔美国人和太平洋岛民心理健康和身体健康影响调查研究(COMPASS)的结果。
J Med Internet Res. 2022 Aug 9;24(8):e38443. doi: 10.2196/38443.
5
Pubertal Timing Across Asian American, Native Hawaiian, and Pacific Islander Subgroups.青春期时间在亚裔美国人、夏威夷原住民和太平洋岛民亚群中的差异。
JAMA Netw Open. 2024 May 1;7(5):e2410253. doi: 10.1001/jamanetworkopen.2024.10253.
6
Characterizing disparities in receipt of palliative care for Asian Americans, Native Hawaiians, and Pacific Islanders with metastatic cancer in the United States.描述美国转移性癌症亚裔美国人、夏威夷原住民和太平洋岛民在接受姑息治疗方面的差异。
Support Care Cancer. 2024 Jul 9;32(8):494. doi: 10.1007/s00520-024-08633-w.
7
Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California.夏威夷和加利福尼亚州亚裔、太平洋岛民和多种族人群中心血管疾病的患病率。
BMC Public Health. 2023 May 15;23(1):885. doi: 10.1186/s12889-023-15795-5.
8
Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders.亚裔美国人、夏威夷原住民和太平洋岛民细分群体宫颈癌确诊时的分期差异。
Am J Obstet Gynecol. 2025 Mar;232(3):310.e1-310.e15. doi: 10.1016/j.ajog.2024.08.027. Epub 2024 Aug 22.
9
Health-Risk Behaviors and Experiences Among Asian American and Native Hawaiian/Pacific Islander Adolescents in the United States, 2011-2019.美国亚裔和美国原住民/太平洋岛民青少年的健康风险行为和经历,2011-2019 年。
Public Health Rep. 2023 Nov-Dec;138(6):925-935. doi: 10.1177/00333549221137325. Epub 2023 Jan 12.
10
Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii.夏威夷综合健康体系中的种族和族裔肺癌筛查
JAMA Netw Open. 2022 Jan 4;5(1):e2144381. doi: 10.1001/jamanetworkopen.2021.44381.

引用本文的文献

1
The history and future of pharmacogenetics in Aotearoa/New Zealand.新西兰的药物遗传学历史与未来。
J R Soc N Z. 2024 Oct 6;55(6):2422-2439. doi: 10.1080/03036758.2024.2406824. eCollection 2025.
2
Major Allele Frequencies in and in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial Categories.亚洲和欧洲人群中[具体内容]的主要等位基因频率:一项在大型种族类别中分解数据的案例研究。
J Pers Med. 2025 Jun 27;15(7):274. doi: 10.3390/jpm15070274.
3
Demographic diversity in platelet function and response to antiplatelet therapy.血小板功能及对抗血小板治疗反应中的人口统计学差异。
Trends Pharmacol Sci. 2025 Jan;46(1):78-93. doi: 10.1016/j.tips.2024.11.005. Epub 2024 Dec 12.
4
Native Hawaiian and Pacific Islander populations in genomic research.基因组研究中的夏威夷原住民和太平洋岛民群体。
NPJ Genom Med. 2024 Sep 30;9(1):45. doi: 10.1038/s41525-024-00428-6.
5
Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.基因检测用于口服 P2Y12 抑制剂治疗:美国心脏协会的科学声明。
Circulation. 2024 Aug 6;150(6):e129-e150. doi: 10.1161/CIR.0000000000001257. Epub 2024 Jun 20.
6
Pharmacogenetic Approaches in Personalized Medicine for Postoperative Pain Management.个性化医疗中术后疼痛管理的药物遗传学方法
Biomedicines. 2024 Mar 25;12(4):729. doi: 10.3390/biomedicines12040729.
7
Maturing pharmacogenomic factors deliver improvements and cost efficiencies.成熟的药物基因组学因素带来了改善和成本效益。
Camb Prism Precis Med. 2022 Oct 6;1:e3. doi: 10.1017/pcm.2022.3. eCollection 2023.
8
The Intersection between Pharmacogenomics and Health Equity: A Case Example.药物基因组学与健康公平性的交叉点:一个案例
Pharmacy (Basel). 2023 Dec 5;11(6):186. doi: 10.3390/pharmacy11060186.
9
The frequency of major , and variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.亚洲、夏威夷原住民和太平洋岛民女性亚组中主要和变体的频率:对个体化他汀类药物剂量的影响。
Pharmacogenomics. 2023 May;24(7):381-398. doi: 10.2217/pgs-2023-0043. Epub 2023 May 24.
10
The frequency of rs2231142 in among Native Hawaiian and Pacific Islander subgroups: implications for personalized rosuvastatin dosing.rs2231142 在夏威夷原住民和太平洋岛民亚群中的频率:对个体化瑞舒伐他汀剂量的影响。
Pharmacogenomics. 2023 Feb;24(3):173-182. doi: 10.2217/pgs-2022-0160. Epub 2023 Jan 20.

本文引用的文献

1
Cardiometabolic genomics and pharmacogenomics investigations in Filipino Americans: Steps towards precision health and reducing health disparities.菲律宾裔美国人的心脏代谢基因组学和药物基因组学研究:迈向精准健康和减少健康差距的步骤。
Am Heart J Plus. 2022 Mar;15. doi: 10.1016/j.ahjo.2022.100136. Epub 2022 Apr 27.
2
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.临床药物遗传学实施联盟 CYP2C19 基因型和氯吡格雷治疗指南:2022 更新版。
Clin Pharmacol Ther. 2022 Nov;112(5):959-967. doi: 10.1002/cpt.2526. Epub 2022 Feb 8.
3
The United States 2020 Census data: implications for precision medicine and the research landscape.美国2020年人口普查数据:对精准医学和研究格局的影响。
Per Med. 2022 Jan;19(1):5-8. doi: 10.2217/pme-2021-0129. Epub 2021 Nov 8.
4
Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation.药物基因变异联盟:一个全球药物基因变异资源库。
Clin Pharmacol Ther. 2021 Sep;110(3):542-545. doi: 10.1002/cpt.2321. Epub 2021 Jun 29.
5
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.CYP2C19*17 等位基因对经皮冠状动脉介入治疗后接受基于基因型的抗血小板治疗患者结局的影响。
Clin Pharmacol Ther. 2021 Mar;109(3):705-715. doi: 10.1002/cpt.2039. Epub 2020 Oct 2.
6
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.临床药物基因组学实施联盟(CPIC)CYP2C19 和质子泵抑制剂剂量指南。
Clin Pharmacol Ther. 2021 Jun;109(6):1417-1423. doi: 10.1002/cpt.2015. Epub 2020 Sep 20.
7
CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study.CYP2C9(*2&*3)和 CYP2C19(*2&*3)多态性与非病灶性癫痫患儿:一项单中心研究。
Acta Neurol Belg. 2021 Dec;121(6):1623-1631. doi: 10.1007/s13760-020-01442-y. Epub 2020 Jul 18.
8
Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients.糖尿病与 CYP2C19 多态性协同作用削弱了经皮冠状动脉介入治疗的急性冠状动脉综合征患者氯吡格雷的抗血小板活性,而替格瑞洛则无此作用。
J Cardiovasc Pharmacol. 2020 Oct;76(4):478-488. doi: 10.1097/FJC.0000000000000881.
9
PharmVar GeneFocus: CYP2C19.药物代谢基因变异数据库重点关注 CYP2C19 基因。
Clin Pharmacol Ther. 2021 Feb;109(2):352-366. doi: 10.1002/cpt.1973. Epub 2020 Jul 22.
10
CYP2C19 Allele Frequencies in Over 2.2 Million Direct-to-Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System.超过 220 万直接面向消费者的基因研究参与者的 CYP2C19 等位基因频率,以及对大型健康系统中处方的潜在影响。
Clin Transl Sci. 2020 Nov;13(6):1298-1306. doi: 10.1111/cts.12830. Epub 2020 Jul 21.

亚洲、夏威夷原住民和太平洋岛民亚组女性主要遗传多态性的频率。

The frequency of major genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups.

机构信息

Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, 410 N 12th Street, Richmond, VA 23298, USA.

Department of Pharmacy Practice, King Faisal University College of Clinical Pharmacy, P.O. Box 400, Hofuf, Eastern Province, 31982, Saudi Arabia.

出版信息

Per Med. 2022 Jul;19(4):327-339. doi: 10.2217/pme-2021-0175. Epub 2022 Jun 24.

DOI:10.2217/pme-2021-0175
PMID:35748236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318053/
Abstract

Prevalence of clinically actionable genetic variants of is lacking in specific population subgroups. This study aims to assess the frequencies of , , and in Asian, Native Hawaiian and Pacific Islander (NHPI) population subgroups compared with Europeans. The study included repository DNA samples of 1064 women, 18 years or older, who self-reported as Filipino, Korean, Japanese, Native Hawaiian, Marshallese and Samoan. The overall frequencies of (25-36%) and (2.5-10%) were significantly higher in all our subgroups than in Europeans (15 and 0.02%, respectively). The overall frequency of was significantly lower in all our subgroups (1-6%) than in Europeans (21.7%). This is the first report on the frequencies of , , and in women of Asian and NHPI descent with distinct population subgroup differences. Differential allele frequencies of among population subgroups underscore the importance of increasing racial and ethnic diversity in pharmacogenetic research.

摘要

在特定人群亚组中,缺乏针对临床可操作的基因突变的流行情况。本研究旨在评估亚洲、夏威夷原住民和太平洋岛民(NHPI)人群亚组与欧洲人相比, 、 和 的频率。该研究包括了 1064 名年龄在 18 岁及以上的自报为菲律宾人、韩国人、日本人、夏威夷原住民、马绍尔群岛人和萨摩亚人的女性的存储库 DNA 样本。我们所有亚组中 (25-36%)和 (2.5-10%)的总体频率明显高于欧洲人(分别为 15%和 0.02%)。我们所有亚组中 (1-6%)的 总体频率明显低于欧洲人(21.7%)。这是第一个关于亚洲和 NHPI 血统女性中 、 和 频率的报告,不同人群亚组存在差异。 等位基因频率在人群亚组中的差异突显了在药物遗传学研究中增加种族和民族多样性的重要性。